Prescient Therapeutics (ASX:PTX) Share Price and News - StockTrack

Market Cap (16-May) $41,071,320 (780th)	Close (30-Jun) $0.081 0 (0%)	Volume (30-Jun) 2,818,974	Shortsold (13-Feb) 21,991 (0.00%) (605th)
52w High $0.063	52w Low $0.037	P/E -	EPS -0.01

	Subject
	PTX PTX Ann: Application for quotation of securities - PTX
	1 (current) 2 3
	PTX PTX Ann: Proposed issue of securities - PTX
	PTX PTX Ann: Share Purchase Plan Booklet
	PTX PTX Ann: Prescient Therapeutics Launches Share Purchase Plan
	PTX PTX Ann: Share Purchase Plan Cleansing Notice
	PTX PTX Ann: PTX Presentation
	PTX PTX Ann: Appendix 4G and Corporate Governance Statement
	PTX PTX Ann: Appendix 4E and 2022 Annual Report
	PTX PTX Ann: PTX agreement with Thermo Fisher for scalable OmniCAR
	PTX PTX Ann: PTX OmniCAR cell manufacturing contract for clinical trials
	PTX PTX Ann: June 2022 Quarterly Update and Appendix 4C
	PTX PTX Ann: Application for quotation of securities - PTX
	PTX PTX Ann: US FDA Grants Orphan Drug Designation to PTX-100 for PTCL
	PTX PTX Ann: Key OmniCAR Patent Granted in US
	PTX PTX Ann: Application for quotation of securities - PTX
	PTX PTX Ann: PTX CellPryme-M presentation
	PTX PTX Ann: PTX unveils new clinic-ready CAR-T enhancement platform
	PTX PTX Ann: Application for quotation of securities - PTX
	PTX PTX Ann: PTX-200 AML expansion after another complete response
	PTX PTX Ann: PTX-200 AML expansion after another complete response
	PTX PTX Ann: Prescient to Present at AVID 2022 Meeting
	PTX PTX Ann: March 2022 Quarterly Update and Appendix 4C
	PTX PTX Ann: Notification of cessation of securities - PTX
	PTX PTX Ann: Application for quotation of securities - PTX
	PTX PTX Ann: Recruitment Open for Expansion Cohort of Phase 1B Study
	PTX PTX Ann: Investor Presentation
	PTX PTX Ann: Appendix 4D and Half Year Financial Report
	PTX PTX Ann: December 2021 Quarterly Update and Appendix 4C
	PTX PTX Ann: Application for quotation of securities - PTX
	PTX PTX Ann: Application for quotation of securities - PTX
	PTX PTX Ann: Section 708A Cleansing Statement
	PTX PTX Ann: PTX adds International CAR-T & Bioengineering Experts to SAB
	PTX PTX Ann: Results of Annual General Meeting
	PTX PTX Ann: AGM Presentation
	PTX PTX Ann: Chair's Address to the 2021 Annual General Meeting
	PTX PTX Ann: Notification regarding unquoted securities - PTX
	PTX PTX Ann: Application for quotation of securities - PTX
	PTX PTX Ann: September 2021 Quarterly Activities and Appendix 4C
	PTX PTX Ann: Investor Presentation - October 2021
	PTX PTX Ann: PTX data demonstrates key OmniCAR features in next gen CAR-T
	PTX PTX Ann: Application for quotation of securities - PTX
	PTX PTX Ann: Notice of Annual General Meeting/Proxy Form
	PTX PTX Ann: Application for quotation of securities - PTX
	PTX PTX Ann: Section 708A Cleansing Statement
	PTX PTX Ann: Notification of cessation of securities - PTX
	PTX PTX Ann: Application for quotation of securities - PTX
	PTX PTX Ann: Section 708A Cleansing Statement
	PTX PTX Ann: Application for quotation of securities - PTX
	PTX PTX Ann: Appendix 4G and Corporate Governance Statement
	PTX PTX Ann: Appendix 4E and 2021 Annual Report

Similar Companies

CSL

Clinuvel Pharmaceuticals

CUV

Immutep

IMM

Imugene

IMU

Mesoblast

MSB

Opthea

OPT

Paradigm Biopharmaceuticals

PAR

PYC Therapeutics

PYC

Race Oncology

RAC

Telix Pharmaceuticals

TLX

End of Day Prices

Date	Close	Volume	Change
15-May	$0.05	121,555	0.00 (0.00%)
14-May	$0.05	45,543	0.00 (0.00%)
12-May	$0.05	1,428,997	+0.00 (2.00%)
08-May	$0.05	444,122	+0.00 (4.17%)
07-May	$0.05	186,348	0.00 (4.00%)
05-May	$0.05	779,857	+0.00 (6.38%)
02-May	$0.05	512,156	0.00 (0.00%)
01-May	$0.05	546,874	+0.00 (2.17%)
30-Apr	$0.05	196,110	0.00 (2.13%)
28-Apr	$0.05	3,062,767	0.00 (4.08%)
24-Apr	$0.05	254,899	+0.00 (8.89%)
17-Apr	$0.05	778,405	+0.00 (2.27%)
16-Apr	$0.04	5,423,191	+0.00 (4.76%)
14-Apr	$0.04	40,355	0.00 (0.00%)
11-Apr	$0.04	13,965	+0.00 (5.00%)
8 up, 3 down, and 4 flat days

High $0.09	Low $0.08	Trades 83	Turnover $220,412	Volume 2,818,974
30 June 2023 at 4:10pm

High $0.09	Low $0.08	Trades 83	Turnover $220,412	Volume 2,818,974
30 June 2023 at 4:10pm

Prescient Therapeutics Health Care
Cancer Therapeutics

$0.081 0.002 (2.53%)

$0.081 0.002 (2.53%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Prescient Therapeutics Health Care Cancer Therapeutics

$0.081 0.002 (2.53%)

$0.081 0.002 (2.53%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Prescient Therapeutics Health Care
Cancer Therapeutics